Evidence map›Paper›PMID 25887889›Full record

ArticleBMC complementary and alternative medicine2015

Rhamnus davurica leaf extract inhibits Fyn activation by antigen in mast cells for anti-allergic activity.

Ji Hyung Kim, A-Ram Kim, Hyuk Soon Kim, Hyun Woo Kim, Young Hwan Park, Jueng Soo You, Yeong Min Park, Erk Her, Hyung Sik Kim, Young Mi Kim and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Treatment Options for Troublesome Itch.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Inhibitory Effects of Angelica Polysaccharide on Activation of Mast Cells.Evidence-based complementary and alternative medicine : eCAM · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ji Hyung KimKU open Innovation Center, School of Medicine, Konkuk University, Chungju, 380-701, Korea. s2877@nate.com.
A-Ram KimKU open Innovation Center, School of Medicine, Konkuk University, Chungju, 380-701, Korea. rhaktyd@kku.ac.kr.
Hyuk Soon KimKU open Innovation Center, School of Medicine, Konkuk University, Chungju, 380-701, Korea. imperial9@kku.ac.kr.
Hyun Woo KimKU open Innovation Center, School of Medicine, Konkuk University, Chungju, 380-701, Korea. hwpierrot@gmail.com.
Young Hwan ParkKU open Innovation Center, School of Medicine, Konkuk University, Chungju, 380-701, Korea. cristalpark@naver.com.
Jueng Soo YouKU open Innovation Center, School of Medicine, Konkuk University, Chungju, 380-701, Korea. jsyou@kku.ac.kr.
Yeong Min ParkKU open Innovation Center, School of Medicine, Konkuk University, Chungju, 380-701, Korea. immun3023@kku.ac.kr.
Erk HerKU open Innovation Center, School of Medicine, Konkuk University, Chungju, 380-701, Korea. erk.her@kku.ac.kr.
Hyung Sik KimCollege of Pharmacy, Sungkyunkwan University, Suwon, 440-746, Korea. hkims@skku.edu.
Young Mi KimCollege of Pharmacy, Duksung Women's University, Seoul, 132-714, Korea. kym123@duksung.ac.kr.
Wahn Soo ChoiKU open Innovation Center, School of Medicine, Konkuk University, Chungju, 380-701, Korea. wahnchoi@kku.ac.kr.
Konkuk University · KRDuksung Women's University · KRSungkyunkwan University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundComplementary and alternative herbal medicines are recently considered as a promising approach for treating various diseases. We screened approximately 100 plant extracts for anti-allergic activity. Rhamnus davurica leaf extract showed the most potent inhibitory effect on the activation of RBL-2H3 mast cells. Although Rhamnus davurica extract has been used to treat pruritus, dysuresia, and constipation as a traditional herbal medicine in some Asian countries, an anti-allergic effect of Rhamnus davurica has not yet been demonstrated. We aimed to investigate the effect and mechanism of the leaf extract of Rhamnus davurica (LERD) on mast cells in vitro and allergic responses in vivo.

methodsThe effects of LERD on the activation of mast cells and mast cell-mediated passive cutaneous anaphylaxis (PCA) were measured in mice and two types of mast cells, mouse bone marrow-derived mast cells (BMMCs) and RBL-2H3 cells in vitro. A mechanistic study of its inhibitory effect was performed by using degranulation assay, reverse transcriptase-polymerase chain reaction, enzyme-linked immunosorbent assay, and western blotting analysis.

resultsLERD reversibly suppressed antigen-stimulated degranulation in BMMCs and RBL-2H3 cells, and also inhibited mRNA expression and secretion of TNF-α and IL-4 in a dose-dependent manner. In a PCA animal model, LERD significantly inhibited antigen-induced allergic response and degranulation of ear tissue mast cells. As for the mechanism of action, LERD inhibited the activation of Syk, which is the pivotal signaling protein for mast cell activation by antigen. Furthermore, LERD also impeded the activations of well-known downstream proteins such as LAT, Akt and three MAP kinases (Erk, p38 and JNK). In an in vitro kinase assay, LERD suppressed the activation of Fyn in antigen-stimulated mast cells.

conclusionThis study demonstrated for the first time that LERD has anti-allergic effects through inhibiting the Fyn/Syk pathway in mast cells. Therefore, this study provides scientific evidence for LERD to be used as an herbal medicine or health food for patients with allergic diseases.

Indexed as

RhamnusAnimalsAnti-Allergic AgentsAntigensCells, CulturedEnzyme-Linked Immunosorbent AssayHumansHypersensitivityImmunoglobulin EInterleukin-4Intracellular Signaling Peptides and ProteinsMaleMast CellsMice, Inbred BALB CPassive Cutaneous AnaphylaxisPhytotherapyAnti-Allergic AgentsAntigensFyn protein, mouseImmunoglobulin EInterleukin-4Intracellular Signaling Peptides and ProteinsPlant ExtractsProtein-Tyrosine KinasesProto-Oncogene Proteins c-fynSyk KinaseSYK protein, humanSyk protein, mouseTNF protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID25887889
PMCPMC4379541
OpenAlexW2147837456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.